[Paraneoplastic retinopathy].
Oguro
Hiroshi
H
Saito
Yoshiyuki
Y
D000912:Antibodies, Neoplasm; D001323:Autoantibodies; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D050883:HSC70 Heat-Shock Proteins / Q000276:immunology; D006801:Humans; D009369:Neoplasms / Q000276:immunology; D009543:Nifedipine / Q000031:analogs & derivatives / Q000627:therapeutic use; D020361:Paraneoplastic Syndromes, Nervous System / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D051603:Recoverin / Q000276:immunology; D012160:Retina / Q000276:immunology; D012164:Retinal Diseases / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy
D000912:Antibodies, Neoplasm; D001323:Autoantibodies; D002121:Calcium Channel Blockers; D050883:HSC70 Heat-Shock Proteins; C035100:nilvadipine; D051603:Recoverin; D009543:Nifedipine